Abstract
Agena Bioscience will partner with molecular decision support company N-of-One to offer interpretation of cancer genomic data generated by Agena’s MassARRAY system.
The partnership will support expansion of Agena’s MassARRAY Insights reporting network, a collaboration between Agena and molecular analysis platform providers designed to aid in interpretation by linking the MassARRAY mass spectrometer with the providers’ analysis software. N-of-One becomes the fifth provider in the reporting network; the other four are Molecular Health, Molecular Match, Pathagility, and Translational Software.
“MassARRAY Insights is part of Agena Bioscience’s continued effort to support our CLIA-High Complexity Certified lab customers who are tackling the challenges presented in molecular diagnostics,” Agena CEO Pete Dansky said in a statement. “We are happy to partner with an industry leader like N-of-One to help bring our lab clients an important component that nicely follows the value of our test: an evidence-based, clinically actionable report.”
JVisentin / Getty Images
